Evaluation of endocrine tests. A: The TRH test in patients with hyperprolactinaemia

Netherlands Journal of Medicine

Volumn 61, Issue 2, 2003, Pages 44-48

  Le Moli, R ^a,b   Endert, E ^a   Fliers, E ^a   Prummel, M F ^a   Wiersinga, W M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; PROTIRELIN; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIFFERENTIAL DIAGNOSIS; ENDOCRINE FUNCTION TEST; FEMALE; FLUOROIMMUNOASSAY; HORMONE RESPONSE; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS; HYPOPHYSIS ADENOMA; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT REFERRAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; STANDARDIZATION; STATISTICAL ANALYSIS; BLOOD; ENDOCRINE SYSTEM EXAMINATION; EVALUATION; HYPOPHYSIS TUMOR; MIDDLE AGED;

ADULT; AGED; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; FLUOROIMMUNOASSAY; HUMANS; HYPERPROLACTINEMIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY NEOPLASMS; PROLACTINOMA; THYROTROPIN-RELEASING HORMONE;

EID: 0038661109     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Sluijmer AV, Lappöhn RE. Clinical history and outcome of 59 patients with idiopathic hyperprolactinaemia. Fertil Steril 1992;58:58-72.
2. Assies J, Schellekens APM, Touber JL. The value of an intravenous TRH test for the diagnosis of tumoural prolactinaemia. Acta Endocrinol 1980;94:439-49.
3. Molitch ME. Prolactinoma. In: The Pituitary. Melmed S (editor). Cambridge: Blackwell, 1995:443-77.
4. Faglia G. The clinical impact of the thyrotropin-releasing hormone test. Thyroid 1998;8:903-8.
5. Le Moli R, Endert E, Fliers E, et al. Establishment of reference values for endocrine tests. II: Hyperprolactinaemia. Neth J Med 1999;55:71-5.
6. Barbieri RL, Cooper DS, Daniels GH, Nathan D, Klibanski A, Ridgway EC. Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hyperprolactinaemia. Fertil Steril 1985;43:66-73.
7. Shangold GA, Kletzky OA, Marrs RP, Mishell DR. Hyperprolactinaemia: comparison of thyrotropic-releasing hormone and tomography. Obstet Gynecol 1984;63:771-5.
8. Klijn JGM, Lamberts SWJ, Jong FH de, Docter R, Dongen KJ van, Birkenhäger JC. The importance of tumour size in patients with hyperprolactinaemia in relation to hormonal variables and extrasellar extension of tumour. Clin Endocrinol 1980;12:341-55.
9. Donders SHJ, Pieters GFFM, Heevel JG, Ross HA, Smals AGH, Kloppenborg PWC. Disparity of thyrotropin (TSH) and prolactin responses to TSH-releasing hormone in obesity. J Clin Endocrinol Metab 1985;61:56-67.